Literature DB >> 32341813

Spastic Diplegia in a Haitian Girl with Angelman Syndrome.

Kumarie Latchman1, Margarita Nieto-Moreno1, Roberto Lopez Alberola2.   

Abstract

Spastic diplegia, a muscle hypertonia motor syndrome, can occur in conjunction with the characteristic abnormal movement features of Angelman syndrome (AS), a neurodevelopmental disorder with primary features of ataxic gait, happy demeanor, developmental delay, speech impairment, intellectual disability, microcephaly, and seizures. Spastic diplegia is classically associated with cerebral palsy (CP), an umbrella term encompassing developmental delay, abnormal brain magnetic resonance imaging findings, and various types of CP including spastic, ataxic, dyskinetic, and mixed types. We present a 12-year-old Haitian patient of African descent with AS due to a microdeletion involving the entire UBE3A (ubiquitin-protein ligase E3A) gene and spastic diplegia. She was initially given a clinical diagnosis of CP. Cases of AS in patients of African descent have been rarely reported and this case of severe spastic diplegia, unresponsive to medical intervention, reflects a rarely reported presentation of AS in patients of African descent and possibly the first reported case of a Haitian patient with this clinical presentation. Given that deletions are the most common mechanism resulting in AS, this case report provides supportive evidence that chromosome 15q11 deletion-type AS is most frequently associated with spastic diplegia, a more severe motor impairment phenotype in AS. © Thieme Medical Publishers.

Entities:  

Keywords:  Angelman syndrome; UBE3A; spastic diplegia

Year:  2019        PMID: 32341813      PMCID: PMC7183405          DOI: 10.1055/s-0039-1697029

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  13 in total

1.  Angelman syndrome 2005: updated consensus for diagnostic criteria.

Authors:  Charles A Williams; Arthur L Beaudet; Jill Clayton-Smith; Joan H Knoll; Martin Kyllerman; Laura A Laan; R Ellen Magenis; Ann Moncla; Albert A Schinzel; Jane A Summers; Joseph Wagstaff
Journal:  Am J Med Genet A       Date:  2006-03-01       Impact factor: 2.802

2.  A novel NIPA1 mutation associated with a pure form of autosomal dominant hereditary spastic paraplegia.

Authors:  Johanna A Reed; Phillip A Wilkinson; Heema Patel; Michael A Simpson; Arnaud Chatonnet; Dimitri Robay; Michael A Patton; Andrew H Crosby; Thomas T Warner
Journal:  Neurogenetics       Date:  2005-02-12       Impact factor: 2.660

Review 3.  The differential diagnosis of spastic diplegia.

Authors:  Richard Huntsman; Edmond Lemire; Jonathon Norton; Anne Dzus; Patricia Blakley; Simona Hasal
Journal:  Arch Dis Child       Date:  2014-11-18       Impact factor: 3.791

4.  Motor impairments, neurological signs, and developmental level in individuals with Angelman syndrome.

Authors:  Eva Beckung; Suzanne Steffenburg; Mårten Kyllerman
Journal:  Dev Med Child Neurol       Date:  2004-04       Impact factor: 5.449

Review 5.  Angelman syndrome - insights into a rare neurogenetic disorder.

Authors:  Karin Buiting; Charles Williams; Bernhard Horsthemke
Journal:  Nat Rev Neurol       Date:  2016-09-12       Impact factor: 42.937

6.  Atp10a, a gene adjacent to the PWS/AS gene cluster, is not imprinted in mouse and is insensitive to the PWS-IC.

Authors:  Amanda J DuBose; Karen A Johnstone; Emily Y Smith; Ryan A E Hallett; James L Resnick
Journal:  Neurogenetics       Date:  2009-11-06       Impact factor: 2.660

7.  Gender influences monoallelic expression of ATP10A in human brain.

Authors:  Amber Hogart; Katherine A Patzel; Janine M LaSalle
Journal:  Hum Genet       Date:  2008-08-23       Impact factor: 4.132

8.  Identification of novel deletions of 15q11q13 in Angelman syndrome by array-CGH: molecular characterization and genotype-phenotype correlations.

Authors:  Trilochan Sahoo; Carlos A Bacino; Jennifer R German; Chad A Shaw; Lynne M Bird; Virginia Kimonis; Irinia Anselm; Susan Waisbren; Arthur L Beaudet; Sarika U Peters
Journal:  Eur J Hum Genet       Date:  2007-05-23       Impact factor: 4.246

9.  Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model.

Authors:  Linyan Meng; Richard Erwin Person; Wei Huang; Ping Jun Zhu; Mauro Costa-Mattioli; Arthur L Beaudet
Journal:  PLoS Genet       Date:  2013-12-26       Impact factor: 5.917

Review 10.  Novel intragenic deletions within the UBE3A gene in two unrelated patients with Angelman syndrome: case report and review of the literature.

Authors:  Cinthia Aguilera; Marina Viñas-Jornet; Neus Baena; Elisabeth Gabau; Concepción Fernández; Nuria Capdevila; Sanja Cirkovic; Adrijan Sarajlija; Marijana Miskovic; Danijela Radivojevic; Anna Ruiz; Miriam Guitart
Journal:  BMC Med Genet       Date:  2017-11-21       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.